JUL 19, 2018 10:00 AM PDT

Medical Marijuana Approved to Replace Opioid Prescriptions in New York State

WRITTEN BY: Mauri Brueggeman

New York State expanded their medical marijuana program in November of 2016.  Since that time the leaders of the State and Health Departments have been working to add qualifying conditions and expand the program further.  Between November of 2016 and today’s date, their medical marijuana program has added a multitude of illnesses or ailments including generalized chronic pain, post-traumatic stress disorder (PTSD), and now, as of this month, opioid use. 

On July 12, 2018, the NY State Department of Health announced that medical marijuana is approved for use as a replacement for opioid prescriptions by registered medical professionals approved within the Medical Marijuana Program. 

New York state, like many states across the country, is being dramatically affected by the costs of the acknowledged opioid epidemic in the United States.  New York is working diligently, in a coordinated effort, to fight addition, reduce opioid related deaths, and fully utilize existing state programs aimed at helping individuals affected by this issue.  The situation has become so dire that in the news brief released by the State, the policies regarding opioid replacement with medical marijuana (within the scope of the state’s Medical Marijuana Program), were considered emergency regulations effective immediately. 

The specific regulations indicate that any condition for which an opioid could be prescribed will be considered a qualifying condition for medical marijuana.  Providers can certify patients to use medical marijuana in place of opioids and temporary ID cards will be available to purchase products in a more streamlined manner.

In addition, this same expansion added that opioid use would also be considered a qualifying condition in order to switch someone from opioids to medical marijuana.  To further the efforts for reducing the burden of the opioid epidemic and create a more accessible medical marijuana program for all, the State has also recently enhanced the Program by permitting home delivery of products and empowering other front-line care providers beyond the MD role, namely Nurse Practitioners and Physician Assistants, the ability to certify patients.

The final permanent regulations on this issue will be adopted on August 1, 2018 after the state has a public comment period between the time these changes were proposed in June and their pilot adoption in July.  According to the NY State Department of Health, there are 62,000 plus certified patients and more than 1700 practitioners participating in the medical marijuana program. 

Sources: NY Department of Health, NY Opioid Epidemic, NY State Medical Marijuana Program,

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
DEC 20, 2019
Health & Medicine
DEC 20, 2019
A Natural Approach to Pain Management
In many instances, pain can be a rather useful tool. It informs individuals that something is amiss with their body and ...
DEC 20, 2019
Cannabis Sciences
DEC 20, 2019
Beware Twitter Bots Spreading False Cannabis Claims
Twitter bots (accounts controlled by software instead of people) are spreading false claims about the medical uses of ca ...
FEB 12, 2020
Cannabis Sciences
FEB 12, 2020
Insurance for Cannabis? Coverage Remains Elusive
Cannabis use can carry a variety of benefits and risks for recreational consumers, patients, doctors and businesses. And ...
MAR 16, 2020
Cannabis Sciences
MAR 16, 2020
Cannabis Reduces ADHD Med Use in New Study
As the legalization of medical cannabis increases in the U.S. and around the globe, its effects on a variety of conditio ...
APR 07, 2020
Cannabis Sciences
APR 07, 2020
Researchers to Study Impact of COVID-19 on Medical Marijuana Patients
Users of medical marijuana are facing delays in receiving their medicines due to disrupted supply chains from the corona ...
APR 23, 2020
Cannabis Sciences
APR 23, 2020
No Difference Between Indica and Sativa Cannabis Strains
Cannabis growers and sellers have defined different strains of cannabis as ‘indica’ or ‘sativa’ ...
Loading Comments...